Diarrhea and Stipsis in Critically Ill Patients (NUTRITI) (NUTRITI)

July 25, 2022 updated by: Cristian Deana, Azienda Sanitaria-Universitaria Integrata di Udine

Gastrointestinal Complications of Artificial Nutrition in ICU: a Prospective Observational Study (NUTRITI)

This study prospectively observed the complications intended as diarrhea or sti-sis that critically ill patients developed within 7 days after ICU admission.

In addition, secondary aims investigated through bioimpedenziometry the loss of lean body mass and changes in phase angle during the same period of ICU stay.

Study Overview

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Udine, Italy, 33100
        • Cristian Deana

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

ADULTS ICU CRITICALLY ILL PATIENTS REQUIRING ICU ADMISSION DUE TO ACUTE ILLNESS WITH ANTICIPATED ICU STAY > 72 HOURS AND NEEDING ARTIFICIAL NUTRITION

Description

Inclusion Criteria:

  • ICU ANTICIPATED LENGTH OF STAY > 72 HOURS
  • AGE > 18 YEARS
  • NEED FOR ARTIFICIAL NUTRITION

Exclusion Criteria:

  • AGE < 18 YEARS
  • ICU ANTICIPATED LENGTH OF STAY < 72 HOURS
  • NO NEED FOR ARTIFICIAL NUTRITION
  • BMI<16 KG/M2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CRITICALLY ILL PATIENTS

ADULTS PATIENTS ADMITTED TO ICU DUE TO ACUTE ILLNESS THAT REQUIRE AT LEAST 72H OF STAY.

FOR THE FIRST 7 DAYS OF STAY IN ICU, DATA ABOUT NUTRITIONAL INTERVENTION WILL BE RECORDED SUCH AS: ROUTE OF NUTRITION ADMINISTRATION, AMOUNT OF NUTRITION DELIVERED PER DAY, CALORIC TARGETS, PROTEIN REQUIREMENTS, diarrhea, CONSTIPATION, BIA ANALYSIS.

ARTIFICIAL NUTRITION

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FREQUENCY OF diarrhea WITHIN 72 HOURS AFTER ICU ADMISSION
Time Frame: 7 DAYS
REGISTER DIARROHEA (EMISSION OF FAECES> 200 ML IN 24 HOURS) EPISODES
7 DAYS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FREQUENCY OF CONSTIPATION WITHIN 7 DAYS AFTER ICU ADMISSION
Time Frame: 7 DAYS
REGISTER CONSTIPATION EPISODES WITHIN 7 DAYS AFTER ADMISSION IN ICU
7 DAYS
LOSS OF LEAN BODY MASS AFTER 7 DAYS IN ICU
Time Frame: 7 DAYS
Loss of at least 7% of lean body mass
7 DAYS
CHANGES IN PHASE ANGLE AFTER 7 DAYS IN ICU
Time Frame: 7 DAYS
Measure of phase angle
7 DAYS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 11, 2019

Primary Completion (ACTUAL)

December 31, 2021

Study Completion (ACTUAL)

July 22, 2022

Study Registration Dates

First Submitted

July 22, 2022

First Submitted That Met QC Criteria

July 22, 2022

First Posted (ACTUAL)

July 26, 2022

Study Record Updates

Last Update Posted (ACTUAL)

July 27, 2022

Last Update Submitted That Met QC Criteria

July 25, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on ARTIFICIAL NUTRITION

Subscribe